Camille MacMillin/STAT

Are MAHA snacks really better for you? Nutrition experts parse a grocery aisle gold rush

From protein Pop-Tarts to avocado-oil chips, a MAHA-fueled snack revolution promises healthier eating. Nutrition experts say it may mostly be illusion.

By Sarah Todd

Live: Robert F. Kennedy Jr. testifies before Senate HELP committee

Live coverage of RFK Jr.'s testimony before the Senate Health, Education, Labor, and Pensions committee on the proposed HHS budget and MAHA priorities.

By Chelsea Cirruzzo and Daniel Payne

Increased calls to 988 hotline associated with a drop in suicides among young people, study finds

A new study finds young people's suicide rates fell after 988 launched, especially where more calls were answered, but funding issues remain.

By Theresa Gaffney

Camille MacMillin/STAT; Sources: AP, CDC, Adobe

Opinion: The CDC’s ‘disease detective’ program turns 75

Celebrating 75 years of the Epidemic Intelligence Service’s crucial work in public health in the U.S. and around the world.

By Eric J. Chow, Ariella Perry Dale, and Matthew Donahue

STAT+ | From Revolution Medicines, more strong data on KRAS drug and a glimpse of a ‘novel class’ beyond it

A company that is changing the outlook on pancreatic cancer has more promising data for treatments near-term and for a generation beyond.

By Angus Chen

STAT+ | Gene therapy trial for deafness adds evidence to drug’s efficacy

Study finds 90% of participants reported significant improvement from an experimental gene therapy designed to treat a rare type of congenital hearing loss.

By O. Rose Broderick

Opinion: Behind every miracle drug is a story

Thomas Goetz, host of "Drug Story," on how his podcast explores the intersection of medication and modern life.

By Torie Bosch

Opinion: NASA’s plans for living in space should prioritize immunology and infectious disease

As NASA moves forward with plans for the moon and Mars, it must consider is the potential impacts of immunology and infectious disease.

By Scott E. Solomon